🔗 Permalink

Inventor profile of:

Ryan Dellinger

City:

Azusa, California

Country:

United States

Published Applications:

Last publication date:

2023-11-02

Top Assignees for applications by Ryan Dellinger

The entities that hold a legal rights for patent applications filed by inventor Dellinger Ryan:

ChromaDex Inc. 8 Irvine, CA United States
Elysium Health, Inc. 7 New York, NY United States
The Queen's University of Belfast 3 Belfast, United Kingdom
ChromaDex Inc. 1 Los Angeles, CA United States
The Queen's University of Belfast 1 Belfast, Ireland
The Queen's University of Belfast 1 Belfast, Northern Ireland, United Kingdom
The Regents of the Unviersity of California 1 Oakland, CA United States
The Regents of the University of California 1 Oakland, CA United States
FUNDACIÓN UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR 1 Valencia, Spain
UNIVERSITAT DE VALÈNCIA ESTUDI GENERAL 1 Valencia, Spain

Recent patent applications by Dellinger Ryan

Ryan Dellinger from Azusa, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-11-02

US20230348521A1

Chemistry; metallurgy

METHODS OF SYNTHESIZING NICOTINAMIDE RIBOSIDE

#2 | 2023-06-29

US20230201233A1

Human necessities

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, AND NICOTINAMIDE MONONUCLEOTIDE, REDUCED NICOTINYL COMPOUNDS, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA FOR HEALTHY DEVELOPMENT

#3 | 2023-03-02

US20230063175A1

Chemistry; metallurgy

Crystalline forms of nicotinamide riboside chloride

#4 | 2022-09-29

US20220305040A1

Human necessities

Nicotinamide riboside for use in treating or preventing liver damage

#5 | 2022-09-29

US20220305039A1

Human necessities

Treating and preventing motor neuron diseases using nicotinamide riboside

#6 | 2021-07-29

US20210228604A1

Human necessities

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

#7 | 2021-07-08

US20210205342A1

Human necessities

Nicotinamide riboside for use in treating or preventing liver damage

#8 | 2021-06-24

US20210186996A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS

#9 | 2021-06-17

US20210177875A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING CHILDHOOD OR TEEN OBESITY

#10 | 2021-04-01

US20210094936A1

Chemistry; metallurgy

Crystalline forms of nicotinamide riboside chloride

#11 | 2020-12-10

US20200384004A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING GLAUCOMA

#12 | 2020-10-22

US20200330497A1

Human necessities

PREVENTION AND TREATMENT OF TDP-43 ASSOCIATED DISEASES

#13 | 2020-10-22

US20200330496A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING PREMATURE AGING DISEASES

#14 | 2020-08-20

US20200261483A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS

#15 | 2020-05-07

US20200140475A1

Chemistry; metallurgy

Methods of synthesizing nicotinamide riboside

#16 | 2020-03-19

US20200085849A1

Human necessities

METHODS AND COMPOSITIONS FOR IMPROVING SLEEP

#17 | 2020-03-05

US20200069711A1

Human necessities

Treating and preventing kidney damage

#18 | 2018-10-25

US20180303861A1

Human necessities

TREATING AND PREVENTING KIDNEY DAMAGE

#19 | 2018-09-13

US20180258127A1

Chemistry; metallurgy

B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof

#20 | 2017-10-26

US20170304338A1

Human necessities

Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors

#21 | 2017-10-19

US20170296564A1

Human necessities

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

#22 | 2017-09-21

US20170267709A1

Chemistry; metallurgy

B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof

#23 | 2016-09-22

US20160272668A1

Chemistry; metallurgy

Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions

#24 | 2015-01-08

US20150011650A1

Human necessities

Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene

InventorID:

1030131 ⎘